Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotensin II.

Many colorectal liver metastases are hypovascular, and their low level of perfusion is associated with limited drug uptake and poor response rates with regional chemotherapy. We have previously shown that hepatic arterial vasoconstrictors may increase drug delivery to liver tumours, but the underlying haemodynamic changes have not been defined. Using intraoperative laser Doppler flowmetry (LDF) we have assessed the effect of intraarterial angiotensin II (AI) on tumour blood flow in ten patients with colorectal liver metastases. Measurements were performed during placement of infusion catheters for regional chemotherapy. Blood flow was recorded continuously with a Periflux PF3 perfusion monitor via a probe held on the tumour surface, following hepatic arterial infusion of 15 micrograms AII over 90 s. Six patients with isolated small metastases (< 5 cm in diameter) showed increases in flow, which reached a peak at 170-240 s from the start of AII infusion, and which were closely correlated with the corresponding increase in arterial pressure (r = 0.92, P = 0.009). Of the four patients with large confluent tumour deposits, two showed smaller transient increases in flow over the first 60 s of AII infusion and two had no measurable flow response. Increased blood flow following AII infusion may increase the exposure of tumour to therapeutic agents. This study suggests that both tumour size and the effect upon systemic arterial pressure may be important determinants of the blood flow response to AII. LDF may provide useful information about the potential of AII and other vasoconstrictors to enhance targeting precision.

• Publication year

  1992

• Venue

  British Journal of Cancer

• Publication date

  1992-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/bjc.1992.392PMID 1419643PMCID 1977985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toxicity tests in animals: historical perspectives and new opportunities.

  1993cited by this paper
• The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour.

  1991cited by this paper
• The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour.

  1991cited by this paper
• Increased capillary flow in intrahepatic tumors due to α‐adrenergic effects of catecholamines

  1988cited by this paper
• Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.

  1987cited by this paper
• Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion.

  1986cited by this paper
• Changes in distribution of hepatic blood flow induced by intra‐arterial infusion of angiotensin II in human hepatic cancer

  1985cited by this paper
• Predicting Tumor Response in Patients with Colorectal Hepatic Metastases

  1985cited by this paper
• A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II.

  1981cited by this paper
• Adrenergic innervation of tumour blood vessels

  1977cited by this paper
• THE INHIBITION BY GLUCAGON OF THE VASOCONSTRICTOR ACTIONS OF NORADRENALINE, ANGIOTENSIN AND VASOPRESSIN ON THE HEPATIC ARTERIAL VASCULAR BED OF THE DOG

  1976cited by this paper
• The blood supply of experimental liver metastases. II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber.

  1970cited by this paper
• The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors.

  1969cited by this paper

• The influence of hepatic arterial blood flow rate on holmium microsphere distribution: an MRI study in perfused porcine livers

  2025cites this paper
• Assessment of myocardial viability using a minimally invasive laser Doppler flowmetry on pig model

  2020cites this paper
• Non-invasive biomedical research and diagnostics enabled by innovative compact lasers

  2017cites this paper
• Application of vasoactive and matrix-modifying drugs can improve polyplex delivery to tumors upon intravenous administration.

  2016cites this paper
• Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice

  2012cites this paper
• SIRT of liver metastases: physiological and pathophysiological considerations

  2012cites this paper
• Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow.

  2008cites this paper
• Local Cancer Therapy with Magnetic Drug Targeting using Magnetic Nanoparticles

  2007cites this paper
• Blood flow in liver tumors--effects of vasoactive drugs estimated with xenon (133Xe) clearance.

  2004cites this paper
• Radiotherapy combined with transarterial infusion chemotherapy and concurrent infusion of a vasoconstrictor agent for nonresectable advanced hepatic hilar duct carcinoma

  2004cites this paper
• Intra-Arterial Infusion Chemotherapy With Angiotensin-II for Locally Advanced and Nonresectable Pancreatic Adenocarcinoma: Further Evaluation and Prognostic Implications

  2003cites this paper
• Laserinduzierte interstitielle Thermotherapie (LITT) — Technik, Indikation und lokale Tumorkontrolle

  2002cites this paper
• Effects of immunosuppressant FTY720 on renal and hepatic hemodynamics in the rat

  2002cites this paper
• Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases

  2001influential citation
• Correlation between angiographically assessed vascularity and blood flow in hepatic metastases in patients with colorectal carcinoma

  2000influential citation
• Disparate responses of tumour vessels to angiotensin II: tumour volume-dependent effects on perfusion and oxygenation

  2000cites this paper
• Noradrenaline improves the tumour to normal blood flow ratio and drug delivery in a model of liver metastases

  1999cites this paper
• Transcatheter Arterial Chemotherapy and Chemoembolization of Liver Metastases

  1999cites this paper
• Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter.

  1998cites this paper
• Theoretical models for drug delivery to solid tumors.

  1997cites this paper
• Effect of continuous regional vasoactive agent infusion on liver metastasis blood flow.

  1997cites this paper
• Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd‐DTPA‐enhanced MRI

  1996cites this paper
• The vascularity of colorectal liver metastases.

  1996cites this paper
• Spatial heterogeneity of tumour blood flow modification induced by angiotensin II: Relationship to receptor distribution

  1996cites this paper
• Vasoactive manipulation to enhance the delivery and uptake of regional infusion chemotherapy in the treatment of colorectal hepatic metastases

  1996cites this paper
• Non-Invasive Quantification of Human Liver Neoplasms by Positron Emission Tomography(PET) Using C15O2 Steady State Method

  1993cites this paper
• Duplex/colour Doppler sonography: measurement of changes in hepatic arterial haemodynamics following intra-arterial angiotensin II infusion.

  1993cites this paper
• Hepatic arterial haemodynamics changes following intra-arterial angiotensin II infusion: duplex/colour Doppler sonography.

  1993cites this paper
• Tumour blood flow: measurement and manipulation for therapeutic gain.

  1993cites this paper